This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Octant, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Kenneth Matthew Whitmore: Innovator in Pharmacological Research
Introduction
Kenneth Matthew Whitmore is a notable inventor based in Boucherville, Canada. He has made significant contributions to the field of pharmacology, particularly in the development of compounds that correct rhodopsin, a crucial protein in the human eye.
Latest Patents
Whitmore holds a patent titled "Pharmacological correctors of rhodopsin and uses thereof." This patent describes pharmacologic correctors of rhodopsin, methods for creating these compounds, pharmaceutical compositions, and medicaments that include these compounds. Furthermore, it outlines methods for using these compounds in the treatment of various diseases.
Career Highlights
Kenneth Matthew Whitmore is associated with Octant, Inc., where he applies his expertise in pharmacological research. His work focuses on innovative solutions that address critical health issues related to vision and other diseases.
Collaborations
Whitmore collaborates with talented individuals such as Jillian R. Sanzone and Tao Zheng, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Kenneth Matthew Whitmore's work in pharmacological research exemplifies the impact of innovation in medicine. His contributions to the understanding and treatment of diseases through rhodopsin correction highlight the importance of continued research and development in this field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile